Recent Comments
Archived Facts

Posts Tagged ‘Novartis’

ZURICH (Reuters) – Swiss drugmaker Novartis posted worse-than-expected third quarter sales on Thursday, dragged down by the loss of a U.S. patent on its top-selling blood pressure drug Diovan and tough comparisons at its Sandoz unit.

Related Posts:

NEW DELHI (Reuters) – Swiss drugmaker Novartis told India’s top court it had demonstrated the improved efficacy of its cancer drug Glivec as the final hearing began on Tuesday of a patent case that could change the rules for the country’s healthcare sector.

Related Posts:

(Reuters) – Idenix Pharmaceuticals Inc said it regained the worldwide rights to develop, market and license its drug candidates from Swiss partner and stakeholder Novartis.

Incoming search terms:

Related Posts:

ZURICH (Reuters) – Novartis said on Monday European regulators approved Afinitor to treat women with a certain type of breast cancer, following a panel backing in June.

Incoming search terms:

Related Posts:

ZURICH (Reuters) – Swiss drugmaker Novartis is hoping key cancer data on both its marketed products as well as promising drugs in its early pipeline will show it can pack a punch in the oncology field at a major industry meeting later this week.

Related Posts:

Novartis AG is bracing for lower profitability this year as key products like top-selling blood pressure drug Diovan face competition from cheaper rivals, the Swiss drugmaker said as it posted an 8 percent rise in quarterly earnings.

Related Posts:

Manufacturing problems at a Novartis factory that triggered the recall of four popular medicines could cost the company between $ 560 million and $ 750 million in lost sales and productivity, a Wall Street analyst estimated Tuesday.

Incoming search terms:

Related Posts:

Novartis’s costly eye drug Lucentis has been rejected for another new use by Britain’s health cost-effectiveness watchdog NICE, following a similar setback in July.

Related Posts:

Novartis’ Sandoz unit has agreed to pay $ 150 million Swiss francs to settle claims it charged the U.S. and state governments inflated prices for drugs, a Swiss newspaper reported on Sunday.

Related Posts:

Swiss drugmaker Novartis said it has applied to start selling its experimental drug to treat smoker’s cough — which afflicts 80 million people worldwide — after tests showed that it helped patients breathe more easily.

Related Posts: